Role of gastritis pattern on Helicobacter pylori eradication

Internal and Emergency Medicine

Volumn 7, Issue 6, 2012, Pages 517-522

  Zullo, Angelo ^a   Severi, Carola ^b   Vannella, Lucy ^c   Hassan, Cesare ^a   Sbrozzi Vanni, Andrea ^c   Annibale, Bruno ^c,d  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Sant'Andrea Hospital ^*  (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

eradication rate; Gastritis pattern; H. pylori; Triple therapy

Indexed keywords

EID: 84869204707     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0730-4     Document Type: Article

References (29)

1. Kandulski A, Selgrad M, Malfertheiner P (2008) Helicobacter pylori infection: a clinical overview. Dig Liver Dis 40: 619-626.
2. Zullo A, Hassan C, Oliveti D, et al. (2011) Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care. Intern Emerg Med. (Online First, 30 March 2011).
3. Annibale B, Capurso G, DelleFave G (2003) The stomach and iron deficiency anaemia: a forgotten link. Dig Liver Dis 35: 288-295.
4. Fujimura K (2005) Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Int J Hematol 81: 113-118.
5. Franceschi F, Brisinda D, Buccelletti F, et al. (2011) Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias. Intern Emerg Med (Online First, 11 May 2011).
6. Graham DY, Fischbach L (2010) Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59: 1143-1153.
7. Zullo A, Hassan C, Campo SMA et al (2004) Evolving therapy for Helicobacter pylori infection. Expert OpinTher Patents 14: 1453-1464.
8. De Francesco V, Zullo A, Margiotta M et al (2004) Sequential treatment for Helicobacter pylori infection does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther 19: 407-414.
9. Abdullahi M, Annibale B, Capoccia D et al (2008) The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg 18: 1450-1454.
10. Gatta L, Di Mario F, Vaira D et al (2011) Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med 6: 35-39.
11. Zullo A, Cristofari F, Bragazzi MC, Hassan C (2011) Helicobacter pylori in immigrants: a ''foreign'' bacterium? Intern Emerg Med 6: 7-8.
12. Dixon MF, Genta RM, Yardley JH et al (1996) Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 20: 1161-1181.
13. Georgopoulos SD, Ladas SD, Karatapanis S et al (2000) Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci 45: 63-67.
14. Severi C, Abdullahi M, Tari R et al (2009) High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis. Dig Liver Dis 41: 555-558.
15. Zullo A, Perna F, Hassan C et al (2007) Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 25: 1429-1434.
16. Caselli M, Zullo A, Maconi G et al (2007) Cervia II Working Group Report 2006: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 39: 782-789.
17. Megraud F, Malfertheiner P, O'Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-781.
18. Scaccianoce G, Hassan C, Panarese A et al (2006) Helicobacter pylori eradication with either seve-day or 10-day triple therapies, and with ad 10-day sequential regimen. Can J Gastroenterol l20: 113-117.
19. Vaira D, Zullo A, Hassan C, et al. (2009) Sequential therapy for Helicobacter pylori eradication: the time is now! Ther Adv Gastroenterol 2317-2322.
20. Goddard AF, Jessa MJ, Barrett DA et al (1996) Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology 111: 358-367.
21. Lambert JR (1996) Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy. Gastroenterology 111: 521-523.
22. Perri F, Clemente R, Festa V et al (1998) Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol 30: 146-150.
23. Maconi G, Parente F, Russo A et al (2001) Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol 96: 359-366.
24. Lai YC, Yang JC, Huang SH (2004) Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World J Gastroenterol 10: 991-994.
25. Zagari RM, Bianchi-Porro G, Fiocca R et al (2007) Comparison of one and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER study. Gut 56: 475-479.
26. Paoluzi P, Iacopini F, Crispino P et al (2006) 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Helicobacter 11: 562-568.
27. Buzas GM (2010) First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective. World J Gastroenterol 16: 3865-3870.
28. Zullo A, De Francesco V, Hassan C et al (2007) The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 56: 1353-1357.
29. Gatta L, Vakil N, Leandro G et al (2009) Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 104: 3069-3079.